We focused on the treatment of breast cancer with Tamoxifen (brand names: Nolvadex, Soltamox), which is FDA approved to treat hormone-receptor positive and early-stage breast cancer patient after chemotherapy and surgery. This evidence concerns the gene NR4A1 and breast carcinoma.